This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobs, J. A.
Right arrow Articles by Stobberingh, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobs, J. A.
Right arrow Articles by Stobberingh, E. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2001, p. 2375-2377, Vol. 45, No. 8
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.8.2375-2377.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Prevalence of Macrolide Resistance Genes in Clinical Isolates of the Streptococcus anginosus ("S. milleri") Group

Jan A. Jacobs,1,* Gilles J. van Baar,1 Nancy H. H. J. London,1 Jeroen H. T. Tjhie,1 Leo M. Schouls,2 and Ellen E. Stobberingh1

Department of Medical Microbiology, University Hospital Maastricht, Maastricht,1 and Research Laboratory for Infectious Diseases, National Institute of Public Health and the Environment, 3720 BA Bilthoven,2 The Netherlands

Received 19 October 2000/Returned for modification 28 November 2000/Accepted 17 May 2001

Twenty-two unrelated erythromycin-resistant anginosus group strains (3.2% resistance rate) were assessed for mechanisms of resistance. Streptococcus anginosus accounted for 16 of the 22 isolates. Fifteen isolates harbored the erm(B) gene. The erm(TR) and the mef(E) genes were carried by two isolates each. In three isolates, none of these resistance genes was detected by PCR.


* Corresponding author. Mailing address: Department of Medical Microbiology, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. Phone: 31-43-387 46 44. Fax: 31-43-387 66 43. E-mail: JJA{at}LMIB.azm.nl.


Antimicrobial Agents and Chemotherapy, August 2001, p. 2375-2377, Vol. 45, No. 8
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.8.2375-2377.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Klaassen, C. H. W., Mouton, J. W. (2005). Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E). Antimicrob. Agents Chemother. 49: 1271-1278 [Full Text]  
  • Rodriguez-Avial, I., Rodriguez-Avial, C., Culebras, E., Picazo, J. J. (2005). In Vitro Activity of Telithromycin against Viridans Group Streptococci and Streptococcus bovis Isolated from Blood: Antimicrobial Susceptibility Patterns in Different Groups of Species. Antimicrob. Agents Chemother. 49: 820-823 [Abstract] [Full Text]  
  • Cerda Zolezzi, P., Laplana, L. M., Calvo, C. R., Cepero, P. G., Erazo, M. C., Gomez-Lus, R. (2004). Molecular Basis of Resistance to Macrolides and Other Antibiotics in Commensal Viridans Group Streptococci and Gemella spp. and Transfer of Resistance Genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48: 3462-3467 [Abstract] [Full Text]  
  • Seppala, H., Haanpera, M., Al-Juhaish, M., Jarvinen, H., Jalava, J., Huovinen, P. (2003). Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. J Antimicrob Chemother 52: 636-644 [Abstract] [Full Text]